This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

End-to-End Compression Anastomosis for Left-sided Colectomy Endo-CAR Study

This study has been completed.
Information provided by:
Niti Medical Technologies Ltd. Identifier:
First received: July 4, 2007
Last updated: June 28, 2011
Last verified: June 2011
the purpose of this study is to evaluate the safety and effectiveness of the Niti CAR-device in the creation of colorectal anastomosis

Condition Intervention Phase
Colorectal Cancer Diverticulitis Device: Niti CAR Phase 2

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)

Further study details as provided by Niti Medical Technologies Ltd.:

Primary Outcome Measures:
  • functioning anastomosis & no occurrence of adverse events related to device use [ Time Frame: during hospitalization and until 3 months after discharge ]


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All

Inclusion Criteria:

  • Patient age over 18
  • Patient schedule for colonic surgery requiring E-t-E anastomosis
  • Patient is able to understand and to sign the Informed Consent Form

Exclusion Criteria:

  • Patient has known allergy to Nickel
  • Patient with bowel obstruction, strangulation, peritonitis, perforation, local or systemic infection
  • Patient on regular steroid medication
  • Patient with preexisting sphincter problems or evidence of extensive local disease of the pelvis
  • Patient following radiation (that compromised the anastomosis)
  • Patient who are undergoing a defunctioning stoma
  • Patient with contraindication to general anesthesia
  • Patient who is currently participating in other clinical trial
  • Patient who refuse consent
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00497263

University Hospitals Gasthuisberg Leuven
Leuven, Brabant, Belgium, 3000
Sponsors and Collaborators
Niti Medical Technologies Ltd.
Principal Investigator: André D'Hoore, MD, PhD University Hospitals Gasthuisberg Leuven
  More Information Identifier: NCT00497263     History of Changes
Other Study ID Numbers: CLP-43-01 Rev 01
Study First Received: July 4, 2007
Last Updated: June 28, 2011

Additional relevant MeSH terms:
Colorectal Neoplasms
Intestinal Neoplasms
Gastrointestinal Neoplasms
Digestive System Neoplasms
Neoplasms by Site
Digestive System Diseases
Gastrointestinal Diseases
Colonic Diseases
Intestinal Diseases
Rectal Diseases
Intraabdominal Infections
Gastroenteritis processed this record on August 18, 2017